Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 €
Currency
Home CSSS00000598053

Structure Info

Chemspace ID
CSSS00000598053 (In-Stock Screening Compounds)
CAS
22203-98-1
MFCD
MFCD11521629
IUPAC Name
5-chloro-N-(3-chlorophenyl)-2-hydroxybenzamide
Mol formula
C13H9Cl2NO2
Mol weight
282 Da
Catalog Number(s)
153802, A490995, AA007P55, AD59077, AG007P7X, AG177700, AL59077, AR007PWX, BBV-82137369, BD330939, CD12094795, CSC000598053, CSCR00023184462, GFA02199, HY-144771, I10711, I10711-0.25G, JH213357, LAN-B89448, LN02151753, PV-001821041389, SAB-104910, SEL10002925, T60538, TS-09240, XAA20398, Y3119915, Z238717, Z68143799, ZXC287871, a1_267868_34852, s_1626_513304_22013206, s_1626____513304____22013206

Properties

LogP
3.97
Heavy atoms count
18
Rotatable bond count
2
Number of rings
2
Carbon bond saturation, Fsp3
0
Polar surface area (Å)
49
Hydrogen bond acceptors count
2
Hydrogen bond donors count
2

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C13H9Cl2NO2
Zoom the structure
CSSS00000598053
 

Items Overall 14 items from 4 suppliers

SupplierLead timeShips fromPurityPackPrice, €Qty
Enamine Ltd5 daysUkraine
To:
901 mg79
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
902 mg81
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
905 mg87
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
9010 mg97
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
9020 mg117
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
995 mg49
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
9910 mg78
Go to cartEnquire
Description: Names: SARS-CoV-2-IN-14; Product Description: SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC 50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally .; Target: SARS-CoV; CAS: 22203-98-1
MedChemExpress EU10 daysSweden
To:
995 mg52
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
9910 mg83
Go to cartEnquire
Description: Names: SARS-CoV-2-IN-14; Product Description: SARS-CoV-2-IN-14 (compound 6) is a potent inhibitor of SARS-CoV-2 with an IC50 of 0.39 μM. SARS-CoV-2-IN-14 is a niclosamide analogue. SARS-CoV-2-IN-14 contains higher stability in human plasma and liver S9 enzymes assay than niclosamide, which can improve bioavailability and half-life when administered orally; Target: SARS-CoV; CAS: 22203-98-1
Targetmol Chemicals Inc30 daysUnited States
To:
9910 mg38
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
9925 mg59
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
9950 mg92
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
99100 mg137
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
99200 mg198
Go to cartEnquire
Description: SARS-CoV-2-IN-14 is a potent and oral inhibitor of SARS-CoV-2 (IC50:0.39 μM), which is an analogue of niclosamide. SARS-CoV-2-IN-14 was more stable than niclosamide in the determination of human plasma and liver S9 enzyme. Oral administration of SARS-CoV-2-IN-14 can improve its bioavailability and half-life.; CAS: 22203-98-1
For a custom pack size or bulk
please drop us a line:Enquire